PanTera signs agreement with Bayer for the supply of actinium-225Agreement demonstrates PanTera’s unique ability to support the radionuclide therapeutics industry in bringing new cancer treatments to patients.13/02/2024Read more PanTera and TerraPower Isotopes join forces to accelerate access to actinium-225Strategic collaboration signed to support the development of radiopharmaceuticals in the fight against cancer26/06/2023Read more IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and the Belgian Nuclear Research Centre SCK CEN today announced the name of their joint-venture: Pantera SA/NV22/09/2022Read more 
